It was revealed that the ability of PBLs from AD patients to produce the anti-inflammatory IL-10 and pro-inflammatory IL-6, which play key roles in the response to bacterial antigens, was closely associated with the value of the API. The gene discussed is IL10; the disease is Alzheimer disease.